Apple continues to lead in the tablet apps processor market and held 61 percent unit share in Q1 2011. In non-iPad tablets, NVIDIA topped with 34.4 percent unit volume share in Q1 2011, thanks to NVIDIA's first-mover advantage with the dual-core Cortex-A9 processors and Honeycomb Android design-wins, says Sravan Kundojjala, analyst on Strategy Analytics’ Handset Component Technologies (HCT) programme.
Provisionally they estimate that NVIDIA's tablet apps processor share increased to 48.6 percent in Q2 2011 with the Tegra 2 processor in multiple tablets from tier-one vendors including the Motorola Xoom, Samsung Galaxy Tab 10.1 and 8.9, Dell Streak 7, LG Optimus Pad 3D, Acer Iconia Tab 500 and Asus Eee Pad Transformer. NVIDIA is expected to maintain this momentum with its upcoming Kal-El quad-core processor.
They estimate that x86 processors accounted for less than 5 percent of total tablet apps processors shipped in Q1 2011. Intel is expected to support Android tablets from later this year which could potentially improve the x86-based processor share in tablets.
Stand-alone apps processors accounted for 93.5 percent of total tablet apps processors shipped in Q1 2011 and they continue to believe stand-alone apps processors will dominate the tablet market in the near-to-medium term given the business model and pricing issues surrounding Wi-Fi-only versus 3G / 4G connectivity integrated tablets. Qualcomm's upcoming LTE Snapdragon processor MSM8960 could potentially increase integrated processors' share in tablets.
“The non-iPad camp is still waiting for a blockbuster product and we believe most tablet apps processor suppliers' fortunes are now tied up with this to see further growth," said Stuart Robinson, Director of Strategy Analytics’ Handset Component Technologies (HCT) programme."We expect Amazon's rumoured tablet and Microsoft's Windows 8 platform will be catalysts for further tablet apps processor vendors dynamics.”
Medical IoT developer licenses 86 Siemens patents for self-healing networks - By Nick Flaherty www.flaherty.co.ukNexeon MedSystems in the US has licensed a portfolio of IoT patents from Marathon Patent Group. The portfolio of 86 pate...